Services

Regulatory Strategy & Biomarker Qualification

Support for advancing biomarkers & drug development tools through regulatory pathways.

- FDA & EMA engagement strategy

- Gap assessments & risk mitigation

- Qualification submission support & advisory services

Evidence Generation & Data Strategy

Strategic guidance for building robust evidence packages & development plans.

- Data strategy development

- Endpoint validation support & strategy

- Statistical & evidentiary planning

Scientific & Regulatory Communications

Expert communication strategies to advance scientific understanding & support regulatory success.

- White papers

- Regulatory briefing documents

- Publications & thought leadership materials

- FDA/EMA meeting prep

Consortium & Stakeholder Leadership

Leadership & coordination for complex multi-stakeholder initiatives.

- Public–private partnership design

- Stakeholder alignment across industry, regulators, academia, & nonprofits

- Workshop, webinar, & scientific meeting planning & execution

Program & Portfolio Strategy

Integrated planning & governance to guide drug development tools from concept to qualification.

- End-to-end biomarker lifecycle planning

- Funding strategy & grant support

- Portfolio prioritization & governance

A digital visualization of blue DNA double helix strands, with glowing particles, set against a dark blue background.

Let’s Work Together

Ready to advance your program? Share a bit about your work and we'll be in touch.